Porphyria cutanea tarda (POT), the most common form of porphyria, is m
anifested as skin photosensitivity caused by excess hepatic production
of uroporphyrin and heptacarboxylporphyrin. In experimental animal mo
dels, ascorbic acid modulates chemically induced uroporphyrin accumula
tion, The purpose of this study was to determine whether ascorbic acid
is decreased in the plasma of patients with PCT. Plasma was obtained
after an overnight fast from 21 PCT patients, 16 of whom were infected
with hepatitis C virus (HCV), and from a separate group of 9 patients
with HCV infection but not PCT, Thirteen PCT patients were studied wh
en they had active disease and 8 after treatment-induced remission. Pl
asma ascorbic acid was low (< 23 mu mol/L) in 11 (85%) of the 13 untre
ated PCT patients and deficient (< 11 mu mol/L) in 8 (62%), Two patien
ts with normal ascorbic acid levels (45 and 62 mu mmol/L) had consumed
multivitamins. In 2 patients with deficient ascorbic acid, plasma lev
els returned to normal after phlebotomy treatment, Of the 8 patients s
tudied during remission, 4 had normal ascorbic acid values and 4 were
deficient (5 to 8 mu mol/L). Plasma ascorbic acid values were normal f
or all patients who had HCV but no PCT, These data suggest that plasma
ascorbic acid concentrations are commonly low in POT, but this decrea
se is unrelated to HCV infection, Ascorbic acid deficiency may be one
of the factors that contributes to the pathogenesis of PCT.